In the past 10 years, stent implantation has become a real alternative to surgery and stent technology has continued to evolve with potential for further modifications since its inception in the early 1990s. Since surgical treatment in congenital heart disease contains lots of risks intravascular stenting comprises an option especially for the treatment of aorta and ductal stenting in congenital heart diesease with duct dependent pulmonary circulation. The best therapeutic approach, e.g., stenting versus surgery, in the treatment of coarctation or ductal stenting to provide pulmonary circulation continue to be debated due to the paucity of long-term clinical and imaging data in both groups.Here, we aim to present our intravascular stenting experiences.

Between 2005-2014 we performed a total of 29 intravasculer stenting treatment to 27 patients. Endication for intravasculer stenting was to treat aort coarctation in 15 adolescents and ductal stenting to provide pulmonary circulation in 12 neonate patients. Two neonates needed restenting because of narrowing of ductus and decreased pulmoner blood flow on their clinical follow up. None of adeloscents needed any other interventions after the procedure including baloon dilatation, restenting or surgery. There wereThere were no major complications during the stent implantation and no deaths related to the procedure.

We believe that; in patients with cyanotic congenital heart disease stenting of the arterial duct is an effective alternative to surgical aorto-pulmonary shunts. And also stent implantation is a first-line therapy in most adolescents with coarctation of the aorta. However; further follow-up is required to determine which treatment (surgery or stenting) a particular patient should undergo to obtain the best results.